Healthcare Sector Stocks
The Healthcare sector has a total of 1056 stocks, with a combined market cap of $9.37 trillion, total revenue of $4.67 trillion and a weighted average PE ratio of 50.10.
Market Cap
9.37T
Revenue
4.67T
Profits
187.1B
PE Ratio
50.10
Profit Margin
4.01%
Dividend Yield
0.38%
1055 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.03T | -1.52% | 3,057,885 | 79.67B |
| 2 | JNJ | Johnson & Johnson | 640.67B | -0.82% | 7,900,418 | 97.93B |
| 3 | ABBV | AbbVie Inc. | 453.12B | 0.37% | 4,315,488 | 64.39B |
| 4 | MRK | Merck & Co., Inc. | 364.55B | -0.40% | 11,126,604 | 66.57B |
| 5 | UNH | UnitedHealth Group Incorporated | 349.53B | -0.90% | 5,748,583 | 450.53B |
| 6 | NVS | Novartis AG | 289.79B | -1.14% | 1,286,182 | 56.69B |
| 7 | AZN | AstraZeneca PLC | 251.73B | -0.35% | 3,068,214 | 61.37B |
| 8 | AMGN | Amgen Inc. | 232.41B | -0.59% | 2,343,377 | 38.10B |
| 9 | TMO | Thermo Fisher Scientific Inc. | 228.17B | -0.82% | 1,429,097 | 46.34B |
| 10 | NVO | Novo Nordisk A/S | 200.97B | -0.61% | 7,607,222 | 50.34B |
| 11 | ABT | Abbott Laboratories | 190.97B | -1.88% | 10,691,544 | 46.59B |
| 12 | GILD | Gilead Sciences, Inc. | 181.46B | 0.45% | 6,594,694 | 30.46B |
| 13 | PFE | Pfizer Inc. | 162.21B | 1.79% | 45,930,350 | 63.70B |
| 14 | DHR | Danaher Corporation | 150.13B | -1.16% | 3,608,445 | 25.11B |
| 15 | VRTX | Vertex Pharmaceuticals Incorporated | 138.01B | 0.52% | 1,198,448 | 12.59B |
| 16 | BMY | Bristol-Myers Squibb Company | 136.47B | 0.35% | 12,682,246 | 49.19B |
| 17 | ISRG | Intuitive Surgical, Inc. | 133.14B | 1.14% | 1,923,583 | 11.03B |
| 18 | SYK | Stryker Corporation | 124.20B | -2.08% | 2,041,060 | 25.84B |
| 19 | CVS | CVS Health Corporation | 120.11B | 0.91% | 10,676,760 | 412.65B |
| 20 | MDT | Medtronic plc | 116.03B | -0.64% | 12,630,525 | 37.54B |
| 21 | SNY | Sanofi | 106.88B | -1.03% | 2,345,027 | 55.89B |
| 22 | MCK | McKesson Corporation | 103.22B | -0.90% | 1,382,719 | 410.98B |
| 23 | GSK | GSK plc | 100.70B | -1.12% | 2,394,076 | 44.05B |
| 24 | HCA | HCA Healthcare, Inc. | 89.73B | -0.81% | 1,306,128 | 78.01B |
| 25 | ELV | Elevance Health, Inc. | 85.13B | -0.48% | 1,090,737 | 201.11B |
| 26 | REGN | Regeneron Pharmaceuticals, Inc. | 79.79B | 0.62% | 894,269 | 15.53B |
| 27 | CI | The Cigna Group | 72.95B | -1.00% | 1,421,773 | 282.38B |
| 28 | BSX | Boston Scientific Corporation | 70.00B | 3.12% | 18,906,225 | 21.00B |
| 29 | ARGX | argenx SE | 63.60B | 0.83% | 227,992 | 5.32B |
| 30 | COR | Cencora, Inc. | 61.75B | 0.49% | 1,387,963 | 332.77B |
| 31 | TAK | Takeda Pharmaceutical Company Limited | 58.42B | -0.28% | 1,779,519 | 28.42B |
| 32 | MRNA | Moderna, Inc. | 56.03B | 1.70% | 18,570,705 | 2.23B |
| 33 | CAH | Cardinal Health, Inc. | 54.57B | 0.03% | 1,673,454 | 254.25B |
| 34 | EW | Edwards Lifesciences Corporation | 52.31B | 0.60% | 4,047,532 | 6.51B |
| 35 | BDX | Becton, Dickinson and Company | 51.24B | -0.74% | 2,629,617 | 22.48B |
| 36 | NTRA | Natera, Inc. | 46.41B | -1.32% | 1,326,119 | 2.71B |
| 37 | VEEV | Veeva Systems Inc. | 46.26B | 3.25% | 2,846,186 | 3.46B |
| 38 | MDLN | Medline Inc. | 46.05B | -0.71% | 8,414,250 | 29.94B |
| 39 | HUM | Humana Inc. | 46.02B | -0.60% | 1,019,963 | 145.68B |
| 40 | RVMD | Revolution Medicines, Inc. | 44.06B | -1.11% | 2,269,459 | - |
| 41 | HLN | Haleon plc | 43.98B | -0.79% | 8,404,575 | 14.80B |
| 42 | IDXX | IDEXX Laboratories, Inc. | 43.86B | 0.31% | 698,427 | 4.55B |
| 43 | A | Agilent Technologies, Inc. | 43.30B | -0.18% | 2,765,723 | 7.37B |
| 44 | IQV | IQVIA Holdings Inc. | 42.99B | -0.21% | 1,303,889 | 16.98B |
| 45 | TEVA | Teva Pharmaceutical Industries Limited | 42.01B | -1.07% | 5,778,766 | 17.32B |
| 46 | ONC | BeOne Medicines AG | 40.88B | -1.95% | 346,055 | 6.13B |
| 47 | WAT | Waters Corporation | 40.74B | -0.01% | 679,237 | 4.64B |
| 48 | RPRX | Royalty Pharma plc | 35.31B | 0.92% | 3,895,210 | 2.54B |
| 49 | ALC | Alcon Inc. | 35.02B | 0.07% | 1,106,683 | 10.86B |
| 50 | RMD | ResMed Inc. | 34.63B | -0.10% | 1,722,129 | 5.65B |
| 51 | DXCM | DexCom, Inc. | 34.36B | 0.26% | 2,999,450 | 4.97B |
| 52 | ILMN | Illumina, Inc. | 32.26B | -0.91% | 2,017,764 | 4.49B |
| 53 | ALNY | Alnylam Pharmaceuticals, Inc. | 32.21B | 1.51% | 1,636,350 | 4.80B |
| 54 | GEHC | GE HealthCare Technologies Inc. | 32.17B | -0.70% | 3,386,434 | 21.27B |
| 55 | BIIB | Biogen Inc. | 32.01B | -0.85% | 831,004 | 10.03B |
| 56 | ZTS | Zoetis Inc. | 31.86B | -0.31% | 5,808,005 | 9.53B |
| 57 | CNC | Centene Corporation | 31.78B | -0.63% | 8,794,645 | 180.30B |
| 58 | MTD | Mettler-Toledo International Inc. | 28.15B | 0.47% | 221,175 | 4.13B |
| 59 | LH | Labcorp Holdings Inc. | 26.98B | -0.73% | 851,157 | 14.35B |
| 60 | INSM | Insmed Incorporated | 26.60B | 2.77% | 2,390,325 | 1.14B |
| 61 | DGX | Quest Diagnostics Incorporated | 26.52B | -1.01% | 1,358,258 | 11.56B |
| 62 | PHG | Koninklijke Philips N.V. | 26.01B | -0.56% | 631,427 | 20.18B |
| 63 | BNTX | BioNTech SE | 25.52B | -0.46% | 1,089,898 | 3.03B |
| 64 | ROIV | Roivant Sciences Ltd. | 25.02B | -0.20% | 39,466,731 | 7.53M |
| 65 | INCY | Incyte Corporation | 24.98B | -0.92% | 1,483,196 | 5.82B |
| 66 | WST | West Pharmaceutical Services, Inc. | 24.01B | 1.08% | 615,601 | 3.33B |
| 67 | STE | STERIS plc | 22.68B | -0.49% | 860,214 | 6.04B |
| 68 | UTHR | United Therapeutics Corporation | 21.89B | -0.99% | 538,523 | 3.15B |
| 69 | THC | Tenet Healthcare Corporation | 21.41B | -0.33% | 830,372 | 21.81B |
| 70 | GH | Guardant Health, Inc. | 21.34B | -1.54% | 1,857,132 | 1.18B |
| 71 | GMAB | Genmab A/S | 19.69B | -0.21% | 1,733,460 | 4.13B |
| 72 | ZBH | Zimmer Biomet Holdings, Inc. | 19.08B | -0.86% | 1,304,314 | 8.51B |
| 73 | VTRS | Viatris Inc. | 18.96B | 1.04% | 12,669,710 | 14.74B |
| 74 | ASND | Ascendis Pharma A/S | 17.27B | 6.10% | 1,026,166 | 1.20B |
| 75 | MEDP | Medpace Holdings, Inc. | 16.58B | -1.11% | 347,286 | 2.78B |
| 76 | JAZZ | Jazz Pharmaceuticals plc | 16.27B | 2.51% | 1,221,019 | 4.60B |
| 77 | NBIX | Neurocrine Biosciences, Inc. | 15.66B | -0.02% | 1,741,100 | 3.37B |
| 78 | SOLV | Solventum Corporation | 15.50B | -0.07% | 926,440 | 8.31B |
| 79 | BBIO | BridgeBio Pharma, Inc. | 14.97B | -0.01% | 2,063,611 | 713.07M |
| 80 | RVTY | Revvity, Inc. | 14.36B | -0.10% | 1,631,781 | 2.91B |
| 81 | CRL | Charles River Laboratories International, Inc. | 13.76B | -1.12% | 1,086,241 | 4.00B |
| 82 | COO | The Cooper Companies, Inc. | 13.67B | -1.52% | 2,156,702 | 4.23B |
| 83 | EXEL | Exelixis, Inc. | 13.54B | 0.35% | 2,246,348 | 2.44B |
| 84 | BAX | Baxter International Inc. | 13.44B | -0.50% | 3,992,223 | 11.47B |
| 85 | ICLR | ICON Public Limited Company | 12.73B | -2.96% | 707,464 | 8.29B |
| 86 | PEN | Penumbra, Inc. | 12.73B | 0.44% | 477,150 | 1.50B |
| 87 | BMRN | BioMarin Pharmaceutical Inc. | 12.63B | 0.87% | 2,299,114 | 3.41B |
| 88 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.48B | 1.17% | 134,578 | 1.28B |
| 89 | CORT | Corcept Therapeutics Incorporated | 12.25B | -0.47% | 636,565 | 830.81M |
| 90 | BTSG | BrightSpring Health Services, Inc. | 12.17B | -1.23% | 1,924,591 | 14.37B |
| 91 | FMS | Fresenius Medical Care AG | 12.14B | -1.56% | 601,233 | 22.19B |
| 92 | SNN | Smith & Nephew plc | 12.12B | -0.72% | 4,304,387 | 6.30B |
| 93 | HALO | Halozyme Therapeutics, Inc. | 12.09B | 1.08% | 1,280,007 | 1.66B |
| 94 | ELAN | Elanco Animal Health Incorporated | 11.95B | -0.79% | 5,359,844 | 5.02B |
| 95 | EHC | Encompass Health Corporation | 11.86B | -0.53% | 720,698 | 6.21B |
| 96 | ARWR | Arrowhead Pharmaceuticals, Inc. | 11.64B | -2.97% | 1,595,519 | 669.50M |
| 97 | TEM | Tempus AI, Inc. | 11.38B | -1.55% | 7,178,313 | 1.43B |
| 98 | ALGN | Align Technology, Inc. | 11.35B | 1.40% | 1,288,371 | 4.14B |
| 99 | TECH | Bio-Techne Corporation | 11.34B | -0.06% | 2,200,643 | 1.22B |
| 100 | DVA | DaVita Inc. | 11.22B | -2.58% | 573,911 | 14.01B |
| 101 | GMED | Globus Medical, Inc. | 10.92B | -1.93% | 1,025,347 | 3.14B |
| 102 | SMMT | Summit Therapeutics Inc. | 10.87B | -0.80% | 5,425,209 | - |
| 103 | KRYS | Krystal Biotech, Inc. | 10.64B | 2.25% | 222,775 | 440.48M |
| 104 | ABVX | ABIVAX Société Anonyme | 10.60B | -1.43% | 1,056,740 | 5.67M |
| 105 | GKOS | Glaukos Corporation | 10.59B | -0.17% | 455,572 | 612.84M |
| 106 | AXSM | Axsome Therapeutics, Inc. | 10.40B | -0.25% | 503,716 | 776.57M |
| 107 | MOH | Molina Healthcare, Inc. | 10.35B | -0.61% | 1,035,248 | 42.47B |
| 108 | BIO | Bio-Rad Laboratories, Inc. | 10.32B | -0.41% | 301,424 | 2.59B |
| 109 | PODD | Insulet Corporation | 10.31B | 2.43% | 6,635,040 | 3.05B |
| 110 | RGEN | Repligen Corporation | 10.21B | 2.67% | 790,973 | 785.10M |
| 111 | RDY | Dr. Reddy's Laboratories Limited | 10.20B | -0.41% | 2,159,619 | 3.50B |
| 112 | APGE | Apogee Therapeutics, Inc. | 10.19B | 0.08% | 1,811,685 | - |
| 113 | UHS | Universal Health Services, Inc. | 10.04B | -0.77% | 756,650 | 18.11B |
| 114 | IONS | Ionis Pharmaceuticals, Inc. | 10.03B | -1.13% | 2,017,160 | 874.09M |
| 115 | HSIC | Henry Schein, Inc. | 10.01B | 0.31% | 1,153,567 | 13.60B |
| 116 | ENSG | The Ensign Group, Inc. | 9.96B | -0.42% | 363,047 | 5.49B |
| 117 | KYMR | Kymera Therapeutics, Inc. | 9.88B | 0.56% | 656,835 | 105.00M |
| 118 | CYTK | Cytokinetics, Incorporated | 9.86B | -1.64% | 3,078,140 | 67.67M |
| 119 | AVTR | Avantor, Inc. | 9.83B | -0.27% | 6,535,594 | 6.56B |
| 120 | PRAX | Praxis Precision Medicines, Inc. | 9.78B | 1.61% | 380,663 | 7.46M |
| 121 | PTGX | Protagonist Therapeutics, Inc. | 9.56B | 2.37% | 567,396 | 281.99M |
| 122 | OSCR | Oscar Health, Inc. | 9.24B | -1.67% | 3,646,372 | 15.32B |
| 123 | PCVX | Vaxcyte, Inc. | 9.04B | 1.50% | 1,748,999 | - |
| 124 | CRNX | Crinetics Pharmaceuticals, Inc. | 9.01B | 0.13% | 8,208,423 | 42.16M |
| 125 | QGEN | Qiagen N.V. | 8.95B | 0.42% | 1,350,434 | 2.10B |
| 126 | BRKR | Bruker Corporation | 8.84B | 1.63% | 1,859,810 | 3.50B |
| 127 | TWST | Twist Bioscience Corporation | 8.72B | -1.68% | 1,892,097 | 431.80M |
| 128 | IMVT | Immunovant, Inc. | 8.43B | -0.92% | 1,391,918 | - |
| 129 | IBRX | ImmunityBio, Inc. | 8.43B | -1.24% | 6,881,640 | 165.79M |
| 130 | ATR | AptarGroup, Inc. | 8.37B | -1.03% | 389,239 | 3.93B |
| 131 | TXG | 10x Genomics, Inc. | 8.14B | 1.48% | 2,656,720 | 616.91M |
| 132 | HQY | HealthEquity, Inc. | 7.99B | 0.18% | 842,006 | 1.36B |
| 133 | ALKS | Alkermes plc | 7.88B | -0.89% | 1,440,889 | 1.67B |
| 134 | SYRE | Spyre Therapeutics, Inc. | 7.88B | -1.14% | 1,913,158 | - |
| 135 | TGTX | TG Therapeutics, Inc. | 7.70B | 0.69% | 1,622,149 | 799.54M |
| 136 | HNGE | Hinge Health, Inc. | 7.47B | 5.96% | 2,003,462 | 720.06M |
| 137 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.31B | -0.97% | 775,190 | 239.92M |
| 138 | CAI | Caris Life Sciences, Inc. | 7.20B | -0.55% | 5,867,529 | 989.61M |
| 139 | SRRK | Scholar Rock Holding Corporation | 6.92B | -1.73% | 987,265 | - |
| 140 | HIMS | Hims & Hers Health, Inc. | 6.90B | 2.57% | 8,308,041 | 2.58B |
| 141 | GRFS | Grifols, S.A. | 6.82B | 0.39% | 623,983 | 8.48B |
| 142 | CHE | Chemed Corporation | 6.75B | -0.89% | 96,647 | 2.60B |
| 143 | PACS | PACS Group, Inc. | 6.70B | -1.03% | 898,519 | 5.55B |
| 144 | CGON | CG Oncology, Inc. | 6.66B | 1.10% | 840,739 | 6.23M |
| 145 | LNTH | Lantheus Holdings, Inc. | 6.59B | 0.19% | 851,768 | 1.56B |
| 146 | MIRM | Mirum Pharmaceuticals, Inc. | 6.37B | 0.61% | 419,813 | 618.07M |
| 147 | BLTE | Belite Bio, Inc | 6.27B | 2.63% | 146,181 | - |
| 148 | ERAS | Erasca, Inc. | 6.25B | -0.83% | 4,766,260 | - |
| 149 | TVTX | Travere Therapeutics, Inc. | 6.25B | 0.93% | 1,891,172 | 591.33M |
| 150 | BLCO | Bausch + Lomb Corporation | 6.24B | 1.92% | 624,846 | 5.32B |
| 151 | KNSA | Kiniksa Pharmaceuticals International, plc | 6.14B | 0.70% | 428,069 | 840.85M |
| 152 | ORKA | Oruka Therapeutics, Inc. | 6.13B | 1.61% | 1,292,889 | - |
| 153 | LQDA | Liquidia Corporation | 6.10B | 0.71% | 1,055,078 | 450.91M |
| 154 | AMRX | Amneal Pharmaceuticals, Inc. | 6.08B | -0.40% | 1,741,995 | 3.12B |
| 155 | COGT | Cogent Biosciences, Inc. | 6.07B | 0.95% | 1,849,679 | - |
| 156 | TFX | Teleflex Incorporated | 6.02B | 1.70% | 653,146 | 2.25B |
| 157 | RDNT | RadNet, Inc. | 5.97B | 1.62% | 658,117 | 2.27B |
| 158 | DNTH | Dianthus Therapeutics, Inc. | 5.91B | -0.22% | 459,376 | 1.90M |
| 159 | STVN | Stevanato Group S.p.A. | 5.85B | 1.90% | 335,717 | 1.40B |
| 160 | XENE | Xenon Pharmaceuticals Inc. | 5.83B | 0.38% | 752,696 | 7.50M |
| 161 | PTCT | PTC Therapeutics, Inc. | 5.80B | -0.78% | 841,097 | 1.01B |
| 162 | MMED | MiniMed Group, Inc. | 5.69B | 0.80% | 2,482,647 | 3.10B |
| 163 | LGND | Ligand Pharmaceuticals Incorporated | 5.66B | 1.29% | 203,702 | 290.54M |
| 164 | CRSP | CRISPR Therapeutics AG | 5.51B | -1.28% | 1,391,037 | 13.39M |
| 165 | MMSI | Merit Medical Systems, Inc. | 5.41B | 0.19% | 407,594 | 1.58B |
| 166 | SHC | Sotera Health Company | 5.39B | -1.92% | 1,891,743 | 1.22B |
| 167 | DFTX | Definium Therapeutics, Inc. | 5.34B | -3.07% | 2,692,610 | - |
| 168 | WAY | Waystar Holding Corp. | 5.02B | -0.23% | 2,375,594 | 1.21B |
| 169 | ACAD | ACADIA Pharmaceuticals Inc. | 4.98B | -0.69% | 1,035,962 | 1.14B |
| 170 | PBLS | Parabilis Medicines, Inc. | 4.82B | -0.26% | 530,036 | 148.00K |
| 171 | DOCS | Doximity, Inc. | 4.76B | -0.07% | 2,194,286 | 655.57M |
| 172 | DYN | Dyne Therapeutics, Inc. | 4.75B | 1.44% | 2,769,268 | - |
| 173 | LFST | LifeStance Health Group, Inc. | 4.72B | 0.41% | 3,446,294 | 1.58B |
| 174 | HAE | Haemonetics Corporation | 4.69B | -0.86% | 494,691 | 1.35B |
| 175 | EWTX | Edgewise Therapeutics, Inc. | 4.54B | -2.32% | 1,085,757 | - |
| 176 | LIVN | LivaNova PLC | 4.40B | -0.63% | 593,717 | 1.47B |
| 177 | HTFL | HeartFlow, Inc. | 4.38B | 5.46% | 2,633,155 | 212.07M |
| 178 | NVST | Envista Holdings Corporation | 4.36B | 0.04% | 1,483,384 | 2.86B |
| 179 | CELC | Celcuity Inc. | 4.36B | 0.70% | 818,973 | - |
| 180 | ICUI | ICU Medical, Inc. | 4.32B | -1.23% | 217,396 | 2.16B |
| 181 | CON | Concentra Group Holdings Parent, Inc. | 4.30B | -1.52% | 838,950 | 2.29B |
| 182 | BLLN | BillionToOne, Inc. | 4.28B | -2.76% | 450,707 | 397.41M |
| 183 | ITGR | Integer Holdings Corporation | 4.26B | -0.06% | 674,677 | 1.84B |
| 184 | ELVN | Enliven Therapeutics, Inc. | 4.24B | 0.05% | 982,051 | - |
| 185 | AMLX | Amylyx Pharmaceuticals, Inc. | 4.24B | -2.85% | 2,728,978 | -665.00K |
| 186 | INDV | Indivior Pharmaceuticals, Inc. | 4.12B | 0.17% | 1,963,276 | 1.33B |
| 187 | MANE | Veradermics, Incorporated | 4.11B | 0.49% | 678,557 | - |
| 188 | RLAY | Relay Therapeutics, Inc. | 4.03B | -2.08% | 3,784,688 | 10.35M |
| 189 | LEGN | Legend Biotech Corporation | 4.03B | 4.53% | 2,322,503 | 1.27B |
| 190 | ADPT | Adaptive Biotechnologies Corporation | 3.98B | -1.07% | 2,237,634 | 308.08M |
| 191 | IRTC | iRhythm Holdings, Inc. | 3.92B | -1.09% | 480,681 | 825.34M |
| 192 | IDYA | IDEAYA Biosciences, Inc. | 3.87B | -0.02% | 977,809 | 234.13M |
| 193 | TNGX | Tango Therapeutics, Inc. | 3.85B | -2.14% | 1,850,353 | 53.81M |
| 194 | VKTX | Viking Therapeutics, Inc. | 3.82B | 1.93% | 1,782,497 | - |
| 195 | DNLI | Denali Therapeutics Inc. | 3.80B | -1.00% | 985,862 | 3.60M |
| 196 | RCUS | Arcus Biosciences, Inc. | 3.73B | 0.24% | 1,106,428 | 117.00M |
| 197 | ABCL | AbCellera Biologics Inc. | 3.72B | 1.15% | 4,955,848 | 66.17M |
| 198 | TLX | Telix Pharmaceuticals Limited | 3.72B | -1.77% | 121,914 | 890.79M |
| 199 | IOVA | Iovance Biotherapeutics, Inc. | 3.70B | 2.00% | 12,126,275 | 324.97M |
| 200 | OGN | Organon & Co. | 3.61B | - | 4,052,474 | 6.13B |
| 201 | PLSE | Pulse Biosciences, Inc. | 3.59B | 5.80% | 657,950 | 1.19M |
| 202 | GRAL | GRAIL, Inc. | 3.55B | -0.79% | 555,941 | 165.26M |
| 203 | OPCH | Option Care Health, Inc. | 3.51B | -1.88% | 1,768,040 | 5.69B |
| 204 | VCYT | Veracyte, Inc. | 3.47B | -0.35% | 1,472,190 | 561.90M |
| 205 | NHC | National HealthCare Corporation | 3.39B | -2.77% | 91,339 | 1.56B |
| 206 | QURE | uniQure N.V. | 3.38B | -0.08% | 1,643,054 | 18.67M |
| 207 | GPCR | Structure Therapeutics Inc. | 3.27B | -3.08% | 1,394,960 | - |
| 208 | TARS | Tarsus Pharmaceuticals, Inc. | 3.26B | 3.46% | 711,972 | 606.33M |
| 209 | IMNM | Immunome, Inc. | 3.11B | -0.58% | 1,050,739 | 4.02M |
| 210 | CLDX | Celldex Therapeutics, Inc. | 3.11B | 1.30% | 696,908 | 158.00K |
| 211 | WRBY | Warby Parker Inc. | 3.04B | -1.60% | 2,304,214 | 911.61M |
| 212 | NAMS | NewAmsterdam Pharma Company N.V. | 3.03B | -2.16% | 1,546,249 | 7.12M |
| 213 | IRON | Disc Medicine, Inc. | 3.02B | -1.72% | 882,042 | - |
| 214 | ARQT | Arcutis Biotherapeutics, Inc. | 3.01B | 0.80% | 1,522,731 | 463.98M |
| 215 | MBX | MBX Biosciences, Inc. | 2.97B | -2.22% | 518,300 | - |
| 216 | TMDX | TransMedics Group, Inc. | 2.94B | -4.03% | 1,185,421 | 668.47M |
| 217 | BEAM | Beam Therapeutics Inc. | 2.94B | 0.38% | 1,308,774 | 156.04M |
| 218 | AVAH | Aveanna Healthcare Holdings Inc. | 2.93B | 0.75% | 4,035,340 | 2.60B |
| 219 | ZLAB | Zai Lab Limited | 2.86B | -2.38% | 920,145 | 449.61M |
| 220 | ALMS | Alumis Inc. | 2.82B | -2.55% | 1,373,435 | 7.40M |
| 221 | BKD | Brookdale Senior Living Inc. | 2.82B | 0.60% | 4,677,927 | 2.93B |
| 222 | ALHC | Alignment Healthcare, Inc. | 2.78B | -1.62% | 2,849,494 | 4.58B |
| 223 | RGC | Regencell Bioscience Holdings Limited | 2.73B | 0.18% | 40,322 | - |
| 224 | AXGN | Axogen, Inc. | 2.73B | -1.38% | 878,137 | 251.17M |
| 225 | ATAI | AtaiBeckley Inc. | 2.72B | 0.69% | 5,221,843 | 4.47M |
| 226 | SLS | SELLAS Life Sciences Group, Inc. | 2.69B | 0.98% | 7,449,606 | - |
| 227 | NRIX | Nurix Therapeutics, Inc. | 2.68B | -1.64% | 1,244,221 | 36.77M |
| 228 | VRDN | Viridian Therapeutics, Inc. | 2.62B | 0.35% | 1,048,761 | 71.13M |
| 229 | PRVA | Privia Health Group, Inc. | 2.62B | -1.44% | 922,124 | 2.36B |
| 230 | CDNA | CareDx, Inc. | 2.59B | 0.64% | 1,534,659 | 458.09M |
| 231 | SUPN | Supernus Pharmaceuticals, Inc. | 2.57B | 1.10% | 535,723 | 830.44M |
| 232 | ACHC | Acadia Healthcare Company, Inc. | 2.57B | -3.47% | 2,076,065 | 3.37B |
| 233 | WGS | GeneDx Holdings Corp. | 2.53B | -1.77% | 504,188 | 454.43M |
| 234 | NEOG | Neogen Corporation | 2.52B | -0.86% | 1,666,736 | 870.40M |
| 235 | PGEN | Precigen, Inc. | 2.48B | -0.29% | 4,135,657 | 85.72M |
| 236 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.48B | -1.22% | 2,756,280 | 940.61M |
| 237 | RARE | Ultragenyx Pharmaceutical Inc. | 2.48B | -1.56% | 1,934,100 | 717.00M |
| 238 | ATRC | AtriCure, Inc. | 2.46B | -0.39% | 529,117 | 569.62M |
| 239 | VERA | Vera Therapeutics, Inc. | 2.46B | -0.32% | 1,536,716 | - |
| 240 | PBH | Prestige Consumer Healthcare Inc. | 2.45B | -1.32% | 472,244 | 1.10B |
| 241 | NKTR | Nektar Therapeutics | 2.44B | -1.57% | 381,518 | 54.59M |
| 242 | PHVS | Pharvaris N.V. | 2.43B | -2.01% | 557,515 | - |
| 243 | BHC | Bausch Health Companies Inc. | 2.38B | 0.79% | 2,508,586 | 10.85B |
| 244 | TRVI | Trevi Therapeutics, Inc. | 2.37B | -1.13% | 1,872,424 | - |
| 245 | GRDN | Guardian Pharmacy Services, Inc. | 2.35B | 0.08% | 298,954 | 1.46B |
| 246 | KOD | Kodiak Sciences Inc. | 2.34B | -0.98% | 1,151,643 | - |
| 247 | NUVB | Nuvation Bio Inc. | 2.34B | - | 3,199,957 | 169.90M |
| 248 | RAPP | Rapport Therapeutics, Inc. | 2.34B | -0.21% | 221,024 | 20.00M |
| 249 | UFPT | UFP Technologies, Inc. | 2.31B | -0.70% | 147,213 | 631.64M |
| 250 | BHVN | Biohaven Ltd. | 2.31B | -0.91% | 2,926,715 | - |
| 251 | OCUL | Ocular Therapeutix, Inc. | 2.30B | 1.25% | 1,520,524 | 52.06M |
| 252 | NEO | NeoGenomics, Inc. | 2.30B | -0.78% | 1,579,102 | 766.30M |
| 253 | HRMY | Harmony Biosciences Holdings, Inc. | 2.29B | 0.43% | 560,160 | 959.90M |
| 254 | MLYS | Mineralys Therapeutics, Inc. | 2.27B | 0.27% | 1,078,167 | - |
| 255 | XRAY | DENTSPLY SIRONA Inc. | 2.23B | 0.45% | 4,428,867 | 3.64B |
| 256 | SRPT | Sarepta Therapeutics, Inc. | 2.22B | 0.81% | 2,656,895 | 1.97B |
| 257 | TRLV | Trulieve Cannabis Corp. | 2.22B | -2.62% | 1,601,514 | 1.14B |
| 258 | CLOV | Clover Health Investments, Corp. | 2.20B | -1.89% | 3,601,637 | 2.48B |
| 259 | PVLA | Palvella Therapeutics, Inc. | 2.20B | 1.75% | 245,780 | - |
| 260 | MESO | Mesoblast Limited | 2.18B | -3.90% | 173,728 | 120.25M |
| 261 | AUPH | Aurinia Pharmaceuticals Inc. | 2.14B | -1.10% | 744,269 | 311.51M |
| 262 | COAG | Hemab Therapeutics Holdings, Inc. | 2.14B | 1.98% | 591,648 | - |
| 263 | HCM | HUTCHMED (China) Limited | 2.13B | -2.10% | 76,275 | 549.12M |
| 264 | ALMR | Alamar Biosciences, Inc. | 2.12B | -0.55% | 325,925 | 100.42M |
| 265 | ZBIO | Zenas BioPharma, Inc. | 2.11B | 3.36% | 527,682 | 1.00M |
| 266 | URGN | UroGen Pharma Ltd. | 2.11B | -1.22% | 749,046 | 188.73M |
| 267 | ADMA | ADMA Biologics, Inc. | 2.10B | 0.54% | 1,756,436 | 512.28M |
| 268 | BFLY | Butterfly Network, Inc. | 2.10B | -6.41% | 5,709,006 | 112.14M |
| 269 | ADUS | Addus HomeCare Corporation | 2.10B | -0.76% | 195,333 | 1.48B |
| 270 | ZYME | Zymeworks Inc. | 2.09B | 4.03% | 716,494 | 37.13M |
| 271 | MD | Pediatrix Medical Group, Inc. | 2.08B | -1.43% | 682,404 | 1.95B |
| 272 | ESTA | Establishment Labs Holdings Inc. | 2.07B | -1.85% | 511,688 | 245.82M |
| 273 | NVCR | NovoCure Limited | 2.06B | -0.95% | 914,820 | 699.19M |
| 274 | NBTX | Nanobiotix S.A. | 2.04B | -1.43% | 113,699 | 38.27M |
| 275 | VCEL | Vericel Corporation | 2.04B | -2.56% | 636,305 | 306.30M |
| 276 | PRGO | Perrigo Company plc | 2.03B | 1.10% | 2,471,921 | 4.14B |
| 277 | XNCR | Xencor, Inc. | 2.03B | 4.62% | 1,808,116 | 104.97M |
| 278 | STOK | Stoke Therapeutics, Inc. | 2.01B | -1.33% | 1,116,087 | 27.59M |
| 279 | AGIO | Agios Pharmaceuticals, Inc. | 2.01B | 1.08% | 1,109,643 | 98.34M |
| 280 | KLRA | Kailera Therapeutics, Inc. | 2.00B | -5.00% | 1,143,983 | - |
| 281 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.98B | -0.52% | 5,318,133 | 208.78M |
| 282 | PGNY | Progyny, Inc. | 1.96B | -1.58% | 911,934 | 1.31B |
| 283 | GENB | Generate Biomedicines, Inc. | 1.96B | -0.39% | 1,552,198 | 26.48M |
| 284 | ASTH | Astrana Health, Inc. | 1.95B | 0.40% | 235,226 | 3.84B |
| 285 | KARD | Kardigan, Inc. | 1.89B | 0.70% | 184,888 | - |
| 286 | CMPS | COMPASS Pathways plc | 1.87B | -1.60% | 1,775,936 | - |
| 287 | IMCR | Immunocore Holdings plc | 1.87B | -0.82% | 271,609 | 430.78M |
| 288 | INBX | Inhibrx Biosciences, Inc. | 1.86B | 2.67% | 388,976 | 1.30M |
| 289 | TSHA | Taysha Gene Therapies, Inc. | 1.85B | -1.39% | 2,063,000 | 5.49M |
| 290 | LKFT | Lakefront Biotherapeutics NV | 1.85B | -1.32% | 133,481 | 1.13B |
| 291 | ALVO | Alvotech | 1.85B | 4.85% | 1,250,840 | 494.61M |
| 292 | GHRS | GH Research PLC | 1.85B | -3.44% | 149,185 | - |
| 293 | VIR | Vir Biotechnology, Inc. | 1.85B | 1.02% | 3,046,562 | 303.23M |
| 294 | LMAT | LeMaitre Vascular, Inc. | 1.84B | -0.21% | 282,758 | 262.43M |
| 295 | RXRX | Recursion Pharmaceuticals, Inc. | 1.82B | 1.80% | 13,911,890 | 54.86M |
| 296 | INSP | Inspire Medical Systems, Inc. | 1.82B | 2.52% | 514,989 | 898.74M |
| 297 | BLFS | BioLife Solutions, Inc. | 1.81B | 1.90% | 1,250,414 | 106.69M |
| 298 | SGRY | Surgery Partners, Inc. | 1.80B | 1.46% | 3,922,632 | 3.37B |
| 299 | PSNL | Personalis, Inc. | 1.79B | -1.70% | 2,845,863 | 69.67M |
| 300 | NTLA | Intellia Therapeutics, Inc. | 1.78B | -1.09% | 2,925,420 | 59.51M |
| 301 | SEPN | Septerna, Inc. | 1.78B | -1.95% | 415,347 | 98.88M |
| 302 | SNDA | Sonida Senior Living, Inc. | 1.78B | 0.11% | 942,213 | 481.07M |
| 303 | FTRE | Fortrea Holdings Inc. | 1.75B | -2.34% | 1,510,174 | 2.68B |
| 304 | DMRA | Damora Therapeutics, Inc. | 1.74B | -2.83% | 497,025 | - |
| 305 | ETON | Eton Pharmaceuticals, Inc. | 1.73B | 1.10% | 768,010 | 105.60M |
| 306 | SNDX | Syndax Pharmaceuticals, Inc. | 1.72B | -1.28% | 1,396,459 | 252.25M |
| 307 | ANAB | AnaptysBio, Inc. | 1.69B | 1.33% | 332,170 | 232.39M |
| 308 | BRVE | Braveheart Bio, Inc. | 1.64B | -7.07% | 806,210 | - |
| 309 | OMCL | Omnicell, Inc. | 1.60B | 6.29% | 1,038,094 | 1.25B |
| 310 | FRNM | Freenome, Inc. | 1.59B | - | 770,302 | 35.41M |
| 311 | ANIP | ANI Pharmaceuticals, Inc. | 1.57B | 0.58% | 340,550 | 978.38M |
| 312 | AAPG | Ascentage Pharma Group International | 1.57B | -6.46% | 6,059 | 94.61M |
| 313 | SLBT | SL Science Holding Limited | 1.56B | 1.11% | 16,270 | 3.27M |
| 314 | ABSI | Absci Corporation | 1.55B | 3.79% | 5,262,838 | 1.56M |
| 315 | NVAX | Novavax, Inc. | 1.55B | 1.19% | 7,271,751 | 413.80M |
| 316 | AVLN | Avalyn Pharma Inc. | 1.54B | 0.12% | 333,132 | - |
| 317 | XERS | Xeris Biopharma Holdings, Inc. | 1.54B | -0.47% | 1,402,581 | 335.41M |
| 318 | PAHC | Phibro Animal Health Corporation | 1.53B | 0.19% | 357,377 | 1.52B |
| 319 | TNDM | Tandem Diabetes Care, Inc. | 1.53B | 2.71% | 1,657,006 | 1.04B |
| 320 | BCAX | Bicara Therapeutics Inc. | 1.53B | -1.32% | 511,966 | - |
| 321 | ARDT | Ardent Health, Inc. | 1.53B | -1.28% | 170,850 | 6.41B |
| 322 | LBRX | LB Pharmaceuticals Inc | 1.52B | -0.98% | 386,951 | - |
| 323 | HCSG | Healthcare Services Group, Inc. | 1.51B | -2.01% | 632,029 | 1.86B |
| 324 | KMTS | Kestra Medical Technologies, Ltd. | 1.51B | 0.43% | 351,297 | 95.13M |
| 325 | OMDA | Omada Health, Inc. | 1.50B | 3.63% | 1,404,750 | 309.76M |
| 326 | INVA | Innoviva, Inc. | 1.50B | -0.95% | 877,333 | 440.00M |
| 327 | TRAX | First Tracks Biotherapeutics, Inc. | 1.49B | -0.05% | 686,989 | - |
| 328 | TYRA | Tyra Biosciences, Inc. | 1.49B | 0.36% | 423,798 | - |
| 329 | CNMD | CONMED Corporation | 1.49B | -0.26% | 288,046 | 1.37B |
| 330 | AVBP | ArriVent BioPharma, Inc. | 1.48B | -0.40% | 369,576 | - |
| 331 | MAZE | Maze Therapeutics, Inc. | 1.48B | -3.17% | 493,521 | 20.00M |
| 332 | AGL | agilon health, inc. | 1.48B | -5.02% | 457,267 | 5.92B |
| 333 | INNV | InnovAge Holding Corp. | 1.47B | -0.55% | 249,767 | 949.17M |
| 334 | SDGR | Schrödinger, Inc. | 1.46B | -1.02% | 652,387 | 259.04M |
| 335 | APMD | Apnimed, Inc. | 1.45B | -11.65% | 475,777 | 120.15M |
| 336 | ATEC | Alphatec Holdings, Inc. | 1.45B | -0.74% | 1,381,746 | 815.05M |
| 337 | REPL | Replimune Group, Inc. | 1.44B | -1.29% | 1,701,428 | - |
| 338 | AKTS | Aktis Oncology, Inc. | 1.44B | 0.50% | 213,617 | 10.06M |
| 339 | AZTA | Azenta, Inc. | 1.43B | -0.91% | 475,581 | 613.81M |
| 340 | CGEM | Cullinan Therapeutics, Inc. | 1.42B | 1.71% | 682,985 | - |
| 341 | ENOV | Enovis Corporation | 1.42B | -1.24% | 672,099 | 2.30B |
| 342 | LTGO | Latigo Biotherapeutics, Inc. | 1.39B | -9.12% | 155,038 | - |
| 343 | ANRO | Alto Neuroscience, Inc. | 1.39B | 0.71% | 764,116 | - |
| 344 | HROW | Harrow, Inc. | 1.38B | -0.97% | 390,196 | 275.59M |
| 345 | SVRA | Savara Inc. | 1.37B | 2.47% | 1,958,683 | - |
| 346 | OMER | Omeros Corporation | 1.36B | 0.97% | 1,330,487 | 38.42M |
| 347 | JBIO | Jade Biosciences, Inc. | 1.36B | 2.50% | 837,037 | - |
| 348 | ORIC | ORIC Pharmaceuticals, Inc. | 1.35B | -1.89% | 1,158,806 | - |
| 349 | VOR | Vor Biopharma Inc. | 1.33B | -0.75% | 847,990 | - |
| 350 | AMN | AMN Healthcare Services, Inc. | 1.33B | -0.98% | 615,243 | 3.43B |
| 351 | MGTX | MeiraGTx Holdings plc | 1.33B | -0.07% | 715,726 | 397.50M |
| 352 | AORT | Artivion, Inc. | 1.32B | 0.82% | 669,066 | 471.47M |
| 353 | IART | Integra LifeSciences Holdings Corporation | 1.32B | 0.18% | 581,070 | 1.65B |
| 354 | DRTS | Alpha Tau Medical Ltd. | 1.30B | -3.62% | 3,116,165 | - |
| 355 | IMTX | Immatics N.V. | 1.30B | 0.85% | 725,255 | 47.65M |
| 356 | NUTX | Nutex Health Inc. | 1.29B | -0.26% | 154,701 | 846.72M |
| 357 | MNKD | MannKind Corporation | 1.29B | 1.52% | 2,805,986 | 393.63M |
| 358 | PNTG | The Pennant Group, Inc. | 1.28B | -0.86% | 272,593 | 1.10B |
| 359 | MLTX | MoonLake Immunotherapeutics | 1.28B | 0.40% | 1,018,116 | - |
| 360 | SPTX | Seaport Therapeutics, Inc. | 1.27B | -1.50% | 117,847 | - |
| 361 | CERT | Certara, Inc. | 1.26B | -0.72% | 1,712,468 | 421.75M |
| 362 | CRON | Cronos Group Inc. | 1.24B | -0.30% | 1,068,285 | 179.09M |
| 363 | PRCT | PROCEPT BioRobotics Corporation | 1.21B | 1.78% | 939,863 | 337.34M |
| 364 | GDRX | GoodRx Holdings, Inc. | 1.19B | -1.13% | 1,055,469 | 785.23M |
| 365 | GLUE | Monte Rosa Therapeutics, Inc. | 1.19B | 4.19% | 1,109,727 | 28.73M |
| 366 | CRVS | Corvus Pharmaceuticals, Inc. | 1.18B | -0.85% | 883,147 | - |
| 367 | ODTX | Odyssey Therapeutics, Inc. | 1.17B | 0.66% | 170,372 | 99.00K |
| 368 | USPH | U.S. Physical Therapy, Inc. | 1.16B | -1.13% | 184,787 | 804.27M |
| 369 | SANA | Sana Biotechnology, Inc. | 1.16B | -1.53% | 2,234,429 | - |
| 370 | TDOC | Teladoc Health, Inc. | 1.15B | -2.46% | 5,132,541 | 2.49B |
| 371 | BVS | Bioventus Inc. | 1.15B | -1.37% | 512,530 | 581.85M |
| 372 | STAA | STAAR Surgical Company | 1.13B | 2.17% | 787,345 | 339.59M |
| 373 | KURA | Kura Oncology, Inc. | 1.13B | -0.08% | 1,964,708 | 77.23M |
| 374 | LMRI | Lumexa Imaging Holdings, Inc. | 1.12B | 1.39% | 260,074 | 1.04B |
| 375 | JANX | Janux Therapeutics, Inc. | 1.11B | 1.05% | 712,590 | 24.00M |
| 376 | IVA | Inventiva S.A. | 1.11B | -0.53% | 1,004,220 | 7.94M |
| 377 | IRMD | IRADIMED CORPORATION | 1.10B | -0.79% | 113,025 | 86.34M |
| 378 | OPK | OPKO Health, Inc. | 1.10B | -0.68% | 2,361,381 | 587.90M |
| 379 | AVTX | Avalo Therapeutics, Inc. | 1.04B | -1.28% | 1,377,267 | 59.00K |
| 380 | PCRX | Pacira BioSciences, Inc. | 1.03B | 0.54% | 380,508 | 746.16M |
| 381 | SLDB | Solid Biosciences Inc. | 1.03B | -1.94% | 686,620 | - |
| 382 | CSTL | Castle Biosciences, Inc. | 1.01B | -1.40% | 258,006 | 357.28M |
| 383 | ABUS | Arbutus Biopharma Corporation | 1.01B | 0.20% | 3,562,202 | 181.72M |
| 384 | IMMX | Immix Biopharma, Inc. | 1.00B | 0.65% | 1,326,817 | - |
| 385 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.00B | -1.75% | 6,653,032 | 41.47M |
| 386 | CADL | Candel Therapeutics, Inc. | 1.00B | - | 895,014 | - |
| 387 | QDEL | QuidelOrtho Corporation | 989.54M | -2.10% | 948,546 | 2.67B |
| 388 | WVE | Wave Life Sciences, Inc. | 965.54M | -2.78% | 3,811,756 | 65.37M |
| 389 | AMPH | Amphastar Pharmaceuticals, Inc. | 958.38M | 2.36% | 274,026 | 730.02M |
| 390 | GERN | Geron Corporation | 957.29M | -1.32% | 7,247,302 | 204.56M |
| 391 | DSGN | Design Therapeutics, Inc. | 944.36M | -0.13% | 704,386 | - |
| 392 | GMRS | GMR Solutions Inc. | 944.32M | -3.57% | 458,619 | 5.88B |
| 393 | ARDX | Ardelyx, Inc. | 941.93M | -0.79% | 3,801,734 | 450.89M |
| 394 | ANNX | Annexon, Inc. | 936.52M | -0.60% | 2,436,869 | - |
| 395 | ATTO | Attovia Therapeutics, Inc. | 920.82M | 3.38% | 181,376 | 1.35M |
| 396 | CBLL | CeriBell, Inc. | 920.31M | 1.05% | 282,737 | 101.96M |
| 397 | ANL | Adlai Nortye Group Ltd. | 913.81M | 2.68% | 139,189 | 18.06M |
| 398 | OLMA | Olema Pharmaceuticals, Inc. | 912.60M | 1.56% | 937,029 | - |
| 399 | BBNX | Beta Bionics, Inc. | 897.54M | 1.17% | 434,873 | 119.01M |
| 400 | ACRS | Aclaris Therapeutics, Inc. | 890.55M | 0.67% | 1,633,151 | 8.22M |
| 401 | TBPH | Theravance Biopharma, Inc. | 884.70M | -0.06% | 383,660 | 104.31M |
| 402 | SGP | SpyGlass Pharma, Inc. | 872.99M | -1.21% | 64,812 | - |
| 403 | RIGL | Rigel Pharmaceuticals, Inc. | 862.64M | -0.65% | 243,090 | 276.79M |
| 404 | INMD | InMode Ltd. | 859.91M | 0.74% | 698,836 | 374.63M |
| 405 | HELP | Cybin Inc. | 859.19M | -3.45% | 1,479,283 | - |
| 406 | SIBN | SI-BONE, Inc. | 852.45M | -0.99% | 301,887 | 213.60M |
| 407 | HSTM | HealthStream, Inc. | 849.42M | -1.12% | 178,209 | 321.12M |
| 408 | FTH | Faeth Therapeutics, Inc. | 846.79M | -3.16% | 173,127 | - |
| 409 | GLAS | Glass House Brands Inc. | 841.59M | -9.62% | 1,397,147 | 176.98M |
| 410 | AVR | Anteris Technologies Global Corp. | 839.12M | -1.49% | 755,618 | 2.24M |
| 411 | ACHV | Achieve Life Sciences, Inc. | 817.05M | -1.98% | 1,059,972 | - |
| 412 | DBVT | DBV Technologies S.A. | 815.91M | 2.07% | 179,194 | 5.04M |
| 413 | SLN | Silence Therapeutics plc | 814.63M | 0.82% | 478,195 | 615.00K |
| 414 | PHAR | Pharming Group N.V. | 811.69M | -1.88% | 12,357 | 366.48M |
| 415 | COLL | Collegium Pharmaceutical, Inc. | 801.19M | -2.92% | 1,035,431 | 808.21M |
| 416 | CLYM | Climb Bio, Inc. | 788.60M | -5.77% | 1,437,486 | - |
| 417 | FDMT | 4D Molecular Therapeutics, Inc. | 779.50M | -3.82% | 1,404,178 | 92.01M |
| 418 | VREX | Varex Imaging Corporation | 779.32M | -0.05% | 763,296 | 865.00M |
| 419 | AHG | Akso Health Group | 771.03M | 5.04% | 6,201 | 13.83M |
| 420 | PHAT | Phathom Pharmaceuticals, Inc. | 760.15M | 4.25% | 1,211,544 | 239.66M |
| 421 | OBX | Obsidian Therapeutics, Inc. | 758.64M | 7.42% | 142,522 | - |
| 422 | OCS | Oculis Holding AG | 756.22M | 0.33% | 114,053 | 1.45M |
| 423 | PHR | Phreesia, Inc. | 754.72M | 0.49% | 613,367 | 495.59M |
| 424 | MNPR | Monopar Therapeutics Inc. | 751.29M | 0.04% | 141,854 | - |
| 425 | AHCO | AdaptHealth Corp. | 745.76M | -3.45% | 2,615,864 | 3.36B |
| 426 | AURA | Aura Biosciences, Inc. | 744.60M | -2.97% | 602,504 | - |
| 427 | NVCT | Nuvectis Pharma, Inc. | 740.58M | -4.21% | 192,565 | - |
| 428 | CTMX | CytomX Therapeutics, Inc. | 732.14M | 4.67% | 2,381,134 | 18.30M |
| 429 | NGNE | Neurogene Inc. | 725.21M | -0.93% | 120,389 | 925.00K |
| 430 | MPLT | MapLight Therapeutics, Inc. | 720.82M | 2.94% | 440,580 | - |
| 431 | SOPH | SOPHiA GENETICS SA | 715.07M | 3.19% | 748,953 | 86.17M |
| 432 | CBIO | Crescent Biopharma, Inc. | 710.50M | -6.48% | 162,999 | 11.88M |
| 433 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 705.53M | 0.69% | 476,039 | - |
| 434 | STTK | Shattuck Labs, Inc. | 703.55M | -0.43% | 751,226 | 1.00M |
| 435 | IRWD | Ironwood Pharmaceuticals, Inc. | 702.27M | 2.91% | 1,669,923 | 389.32M |
| 436 | DRUG | Bright Minds Biosciences Inc. | 700.83M | -1.48% | 52,438 | - |
| 437 | ZVRA | Zevra Therapeutics, Inc. | 697.17M | 1.47% | 818,901 | 136.07M |
| 438 | GYRE | Gyre Therapeutics, Inc. | 696.64M | -0.30% | 41,715 | 109.82M |
| 439 | ALLO | Allogene Therapeutics, Inc. | 690.98M | -0.99% | 4,376,901 | 4.64M |
| 440 | ASMB | Assembly Biosciences, Inc. | 684.73M | -1.29% | 235,972 | 74.85M |
| 441 | SSII | SS Innovations International, Inc. | 683.31M | -2.01% | 21,223 | 52.40M |
| 442 | CTEV | Claritev Corporation | 675.02M | 1.12% | 139,414 | 994.67M |
| 443 | EVO | Evotec SE | 670.12M | -1.57% | 65,936 | 819.47M |
| 444 | ANGO | AngioDynamics, Inc. | 666.69M | 1.77% | 358,533 | 320.17M |
| 445 | MDXG | MiMedx Group, Inc. | 661.75M | 0.89% | 1,063,480 | 355.17M |
| 446 | VSTM | Verastem, Inc. | 653.87M | - | 1,324,422 | 87.53M |
| 447 | AGMB | AgomAb Therapeutics NV | 648.60M | - | 105,443 | - |
| 448 | CRMD | CorMedix Inc. | 643.82M | -0.48% | 980,536 | 462.25M |
| 449 | AQST | Aquestive Therapeutics, Inc. | 641.36M | 1.79% | 1,908,013 | 54.09M |
| 450 | PRME | Prime Medicine, Inc. | 638.68M | -0.55% | 2,092,566 | 4.07M |
| 451 | SGMT | Sagimet Biosciences Inc. | 637.75M | -2.75% | 688,437 | - |
| 452 | OABI | OmniAb, Inc. | 636.81M | -2.01% | 1,179,889 | 38.46M |
| 453 | RGNX | REGENXBIO Inc. | 627.13M | -1.66% | 1,612,317 | 174.48M |
| 454 | AUTL | Autolus Therapeutics plc | 625.48M | 0.43% | 1,197,017 | 117.39M |
| 455 | CTKB | Cytek Biosciences, Inc. | 621.32M | 2.14% | 958,631 | 206.71M |
| 456 | TLRY | Tilray Brands, Inc. | 619.76M | -0.44% | 2,436,376 | 915.45M |
| 457 | CTNM | Contineum Therapeutics, Inc. | 610.97M | -4.75% | 360,162 | - |
| 458 | KIDS | OrthoPediatrics Corp. | 608.62M | -1.44% | 130,091 | 252.72M |
| 459 | ALT | Altimmune, Inc. | 604.95M | - | 2,216,476 | 31.00K |
| 460 | STLN | Starling Oncology, Inc. | 602.32M | -4.21% | 1,345,713 | 587.24M |
| 461 | ARVN | Arvinas, Inc. | 601.55M | 0.22% | 659,721 | 316.70M |
| 462 | EOLS | Evolus, Inc. | 600.40M | 2.36% | 1,026,685 | 316.49M |
| 463 | BWAY | BrainsWay Ltd. | 599.92M | 1.54% | 80,929 | 60.70M |
| 464 | SPRY | ARS Pharmaceuticals, Inc. | 596.68M | 1.87% | 1,984,647 | 116.93M |
| 465 | VALN | Valneva SE | 596.47M | -2.02% | 11,553 | 163.30M |
| 466 | TECX | Tectonic Therapeutic, Inc. | 585.31M | -15.95% | 719,570 | - |
| 467 | WEAV | Weave Communications, Inc. | 584.79M | 0.27% | 1,803,591 | 257.79M |
| 468 | PRLD | Prelude Therapeutics Incorporated | 576.77M | 2.38% | 737,667 | 22.42M |
| 469 | CAPR | Capricor Therapeutics, Inc. | 576.16M | 3.34% | 4,558,778 | 11.13M |
| 470 | SCTX | Scribe Therapeutics Inc. | 576.12M | 7.38% | 151,094 | 36.28M |
| 471 | PROK | ProKidney Corp. | 571.39M | 3.28% | 1,261,896 | 818.00K |
| 472 | DCTH | Delcath Systems, Inc. | 571.14M | 0.73% | 402,691 | 95.42M |
| 473 | EIKN | Eikon Therapeutics, Inc. | 566.57M | -4.74% | 290,729 | - |
| 474 | BLSM | BlossomHill Therapeutics, Inc. | 560.78M | -6.44% | 101,562 | - |
| 475 | ARTV | Artiva Biotherapeutics, Inc. | 552.46M | 1.89% | 249,844 | 251.00K |
| 476 | FLGT | Fulgent Genetics, Inc. | 532.97M | -1.22% | 407,408 | 323.93M |
| 477 | CERS | Cerus Corporation | 532.03M | -0.38% | 1,321,177 | 221.55M |
| 478 | ZURA | Zura Bio Limited | 530.89M | -3.15% | 1,383,179 | - |
| 479 | CABA | Cabaletta Bio, Inc. | 527.29M | -0.32% | 3,030,486 | - |
| 480 | KYTX | Kyverna Therapeutics, Inc. | 524.12M | 1.25% | 484,454 | - |
| 481 | OVID | Ovid Therapeutics Inc. | 521.45M | -4.64% | 1,392,943 | 1.58M |
| 482 | TCMD | Tactile Systems Technology, Inc. | 520.55M | -0.78% | 278,324 | 350.31M |
| 483 | ENTX | Entera Bio Ltd. | 510.77M | -2.64% | 214,455 | 42.00K |
| 484 | EVH | Evolent Health, Inc. | 508.77M | -2.17% | 2,533,014 | 2.10B |
| 485 | MCTA | Charming Medical Limited | 504.26M | -0.85% | 4,251,392 | 4.81M |
| 486 | NPCE | NeuroPace, Inc. | 502.85M | 1.67% | 148,264 | 106.99M |
| 487 | SRTA | Strata Critical Medical, Inc. | 500.72M | -5.19% | 966,085 | 255.98M |
| 488 | RZLT | Rezolute, Inc. | 489.95M | 1.52% | 749,091 | - |
| 489 | SENS | Senseonics Holdings, Inc. | 488.03M | -1.07% | 366,685 | 48.55M |
| 490 | PRTA | Prothena Corporation plc | 480.00M | 0.21% | 335,150 | 54.53M |
| 491 | VOGX | Vogenx, Inc. | 473.20M | 0.12% | 26,001 | - |
| 492 | KMDA | Kamada Ltd. | 471.79M | -0.72% | 94,934 | 191.85M |
| 493 | PBYI | Puma Biotechnology, Inc. | 470.26M | 0.55% | 242,883 | 231.24M |
| 494 | EDIT | Editas Medicine, Inc. | 469.95M | -3.16% | 2,076,018 | 47.01M |
| 495 | SGHT | Sight Sciences, Inc. | 468.25M | -0.58% | 205,487 | 83.38M |
| 496 | RLMD | Relmada Therapeutics, Inc. | 465.08M | 0.69% | 628,243 | - |
| 497 | NRC | NRC Health | 463.18M | -4.16% | 96,935 | 140.00M |
| 498 | CLPT | ClearPoint Neuro, Inc. | 461.83M | -2.64% | 414,652 | 42.28M |
| 499 | EVMN | Evommune, Inc. | 459.46M | -4.31% | 571,963 | 10.00M |
| 500 | DNA | Ginkgo Bioworks Holdings, Inc. | 458.59M | -2.16% | 1,209,393 | 132.42M |